Blog Details

FDA advisers vote against sleep peptide as they debate safety and health claims

FDA advisers vote against sleep peptide as they debate safety and health claims

The FDA’s advisory committee is meeting for two days to discuss whether seven peptides — which have become popular in wellness circles — should be allowed to be compounded.

Read the full article on MarketWatch ?

Start Trading Today

Join thousands of traders and investors. Discover how specific trading strategies work — and get started with your investment journey.